Physician profile
Rex P Lagerstrom
NPI 1083679880
$1,356.87
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $906 · 2020: $410 · 2021: $41.42.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $237.66 | 2019-2020 | |
| Novo Nordisk INC | $164.92 | 2019-2020 | |
| Glaxosmithkline, LLC. | $129.13 | 2019-2020 | |
| Astellas Pharma US INC | $127.65 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $119.14 | 2019-2020 | |
| Abbvie INC. | $98.97 | 2019-2020 | |
| Amarin Pharma, INC. | $96.59 | 2019-2020 | |
| Lilly USA, LLC | $49.22 | 2019-2020 | |
| Pfizer INC. | $37.81 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.41 | 2019-2020 | |
| Circassia INC. | $29.87 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.80 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.79 | 2020 | |
| Allergan, INC. | $16.62 | 2020 | |
| Promius Pharma LLC | $15.95 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $15.89 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.84 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.64 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.48 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.65 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.39 | 2020 | |
| Mdd US Operations, LLC | $11.97 | 2019 | |
| Merck Sharp & Dohme LLC | $11.72 | 2020 | |
| Vivus LLC | $11.57 | 2019 | |
| Lifescan, INC. | $11.18 | 2021 | |
| Eisai INC. | $11.05 | 2020 | |
| Sanofi Pasteur INC. | $10.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Lagerstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.